Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance( )

AIMS: Genetic testing in relatives of hypertrophic cardiomyopathy (HCM) patients leads to early identification of pathogenic DNA variant carriers (G+), before the onset of left ventricular hypertrophy. Routine phenotyping consists of electrocardiography (ECG) and transthoracic echocardiography (TTE)...

Descripción completa

Detalles Bibliográficos
Autores principales: Huurman, Roy, van der Velde, Nikki, Schinkel, Arend F L, Hassing, H Carlijne, Budde, Ricardo P J, van Slegtenhorst, Marjon A, Verhagen, Judith M A, Hirsch, Alexander, Michels, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365305/
https://www.ncbi.nlm.nih.gov/pubmed/35670722
http://dx.doi.org/10.1093/ehjci/jeac099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365305/
https://www.ncbi.nlm.nih.gov/pubmed/35670722
http://dx.doi.org/10.1093/ehjci/jeac099

Ejemplares similares